NeuBase Therapeutics
(NASDAQ:NBSE)
$0.43
-0.0047[-1.08%]
Last update: 2:07PM Get Real Time Here
37.5%
Overview Rating
Speculative
Technicals Analysis
33
0100
Financials Analysis
40
0100

NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary

NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.

Open$0.425
Close-
Volume / Avg.208.061K / 241.441K
Day Range0.403 - 0.433
52 Wk Range0.415 - 5.400
Market Cap$1.604M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
24
Short Interest
0.26%
Days to Cover1
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
0
0
0
0
Feb
0
0
0
0
Jan
0
0
0
0
Dec 23
0
0
0
0
Nov 23
0
0
0
0
Oct 23
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
1.8
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
About NeuBase Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the dev...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
NBSE
DRMA

FAQ

Q

How do I buy NeuBase Therapeutics (NBSE) stock?

A

You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeuBase Therapeutics's (NBSE) competitors?

Q

What is the target price for NeuBase Therapeutics (NBSE) stock?

A

The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeuBase Therapeutics (NBSE)?

A

The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.43 last updated Today at March 28, 2024 at 2:07 PM EDT.

Q

Does NeuBase Therapeutics (NBSE) pay a dividend?

A

There are no upcoming dividends for NeuBase Therapeutics.

Q

When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?

A

NeuBase Therapeutics’s Q2 earnings are confirmed for Thursday, May 9, 2024.

Q

Is NeuBase Therapeutics (NBSE) going to split?

A

There is no upcoming split for NeuBase Therapeutics.

Q

What sector and industry does NeuBase Therapeutics (NBSE) operate in?

A

NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch